Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions

SM Huang - Clinical pharmacology & therapeutics, 2012 - Wiley Online Library
Physiologically based pharmacokinetic (PBPK) models are increasingly used by drug
developers to evaluate the effect of patient factors on drug exposure. Between June 2008 …
被引用次数：221 相关文章

[引用][C] Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions

P Zhao, M Rowland, SM Huang - Clinical Pharmacology & Therapeutics, 2012 - cir.nii.ac.jp
Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to
Address Clinical Pharmacology Regulatory Questions | CiNii Research CiNii 国立情報学研究所 …

Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions.

P Zhao, M Rowland, SM Huang - Clinical Pharmacology & …, 2012 - search.ebscohost.com
Physiologically based pharmacokinetic (PBPK) models are increasingly used by drug
developers to evaluate the effect of patient factors on drug exposure. Between June 2008 …

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions

P Zhao, M Rowland, SM Huang - Clinical …, 2012 - research.manchester.ac.uk
Physiologically based pharmacokinetic (PBPK) models are increasingly used by drug
developers to evaluate the effect of patient factors on drug exposure. Between June 2008 …

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions.

P Zhao, M Rowland, SM Huang - Clinical Pharmacology and …, 2012 - europepmc.org
Physiologically based pharmacokinetic (PBPK) models are increasingly used by drug
developers to evaluate the effect of patient factors on drug exposure. Between June 2008 …

Best practice in the use of physiologically based pharmacokinetic modeling and simulation to address clinical pharmacology regulatory questions

P Zhao, M Rowland, SM Huang - Clinical pharmacology …, 2012 - pubmed.ncbi.nlm.nih.gov
Physiologically based pharmacokinetic (PBPK) models are increasingly used by drug
developers to evaluate the effect of patient factors on drug exposure. Between June 2008 …

[引用][C] Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions

P ZHAO, M ROWLAND… - Clinical pharmacology …, 2012 - Nature Publishing Group